Table 2.
Severity of potential immune adverse events (N = 15)
Adverse event | NCI CTCAE grade | Total | ||
---|---|---|---|---|
1 | 2 | 3 | ||
Back pain | 1 | 1 | ||
Diarrhea | 1 | 1 | 2 | |
Dyspepsia | 0 | 1 | 1 | |
Rash | 1 | 1 | ||
Elevated amylase levels | 0 | 1 | 1 | |
Elevated liver enzyme levels | 1 | 1 | 1 | 3 |
Elevated creatinine levels | 0 | 1 | 1 | |
Hypothyroidism | 1 | 1 | 2 | |
Hyperthyroidism | 1 | 1 | 2 | |
Arthralgia | 0 | 0 | 1 | 1 |
NA not applicable, NCI CTCAE National Cancer Institute Common Terminology Criteria for Adverse Events